These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 34721)

  • 1. Use of the butaclamol template in a search for antipsychotic agents with lessened side effects.
    Kukla MJ; Bloss JL; Brougham LR
    J Med Chem; 1979 Apr; 22(4):401-6. PubMed ID: 34721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptics related to butaclamol. An investigation of the effects of chlorine substituents on the aromatic rings.
    Humber LG; Sideridis N; Asselin AA; Bruderlein FT; Voith K
    J Med Chem; 1978 Dec; 21(12):1225-31. PubMed ID: 31480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the dopamine receptor. 1. Features derived from modifications in ring E of the neuroleptic butaclamol.
    Humber LG; Bruderlein FT; Philipp AH; Götz M
    J Med Chem; 1979 Jul; 22(7):761-7. PubMed ID: 571916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptics related to butaclamol. Synthesis and some psychopharmacological effects of a series of 3-aryl analogues.
    Voith K; Bruderlein FT; Humber LG
    J Med Chem; 1978 Jul; 21(7):694-8. PubMed ID: 27637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the dopamine receptor. 2. Features derived from modifications in the rings A/B region of the neuroleptic butaclamol.
    Philipp AH; Humber LG; Voith K
    J Med Chem; 1979 Jul; 22(7):768-73. PubMed ID: 571917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic activity of four analogs of butaclamol.
    Collu R; Bouvier C; Basak A; Dugas H
    Pharmacol Res Commun; 1985 Dec; 17(12):1153-7. PubMed ID: 2419927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Chloro-2-phenyl-1-benzo[b]thiophene-3-alkanimines, potential antipsychotic agents.
    Kukla MJ; Woo CM; Kehr JR; Miller A
    J Med Chem; 1978 Apr; 21(4):348-52. PubMed ID: 25967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]dihydroergocryptine binding to bovine striatal membranes defined by a low d-butaclamol concentration: antagonism by substituted benzamides.
    Lin CW; Maayani S; Wilk S
    Biochem Pharmacol; 1981 Jun; 30(11):1305-14. PubMed ID: 6168265
    [No Abstract]   [Full Text] [Related]  

  • 9. Chloro-substituted, sterically hindered 5,11-dicarbo analogues of clozapine as potential chiral antipsychotic agents.
    Davis DA; de Paulis T; Janowsky A; Smith HE
    J Med Chem; 1990 Feb; 33(2):809-14. PubMed ID: 1967652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chlorine substituents on the benzene rings of an analogue of the antipsychotic drug butaclamol on the interaction with dopamine and muscarinic receptors in rat brain.
    Pugsley TA; Lippmann W
    J Pharm Pharmacol; 1979 Jan; 31(1):47-9. PubMed ID: 32368
    [No Abstract]   [Full Text] [Related]  

  • 11. Binding of 5H-dibenzo[b,e][1,4]diazepine and chiral 5H-dibenzo[a,d]cycloheptene analogues of clozapine to dopamine and serotonin receptors.
    Phillips ST; de Paulis T; Baron BM; Siegel BW; Seeman P; Van Tol HH; Guan HC; Smith HE
    J Med Chem; 1994 Aug; 37(17):2686-96. PubMed ID: 8064797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of some 2-amino-4-aryl-3H-1,5-benzodiazepine analogues of clozapine.
    Ellefson CR; Woo CM; Miller A; Kehr JR
    J Med Chem; 1978 Sep; 21(9):952-7. PubMed ID: 31487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pKa of butaclamol and the mode of butaclamol binding to central dopamine receptors.
    Chrzanowski FA; McGrogan BA; Maryanoff BE
    J Med Chem; 1985 Mar; 28(3):399-400. PubMed ID: 2579238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct effect of neuroleptics on glutamate release.
    Sherman AD; Mott J
    Neuropharmacology; 1984 Nov; 23(11):1253-9. PubMed ID: 6084822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterically hindered 5,11-dicarbo analogues of clozapine as potential chiral antipsychotic agents.
    Rupard JH; de Paulis T; Janowsky A; Smith HE
    J Med Chem; 1989 Oct; 32(10):2261-8. PubMed ID: 2571728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the stereoisomers of butaclamol on neurotensin content in discrete regions of the rat brain.
    Bissette G; Dauer WT; Kilts CD; O'Connor L; Nemeroff CB
    Neuropsychopharmacology; 1988 Dec; 1(4):329-35. PubMed ID: 2472151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of 5H-dibenzo[a,d]cycloheptene and dibenz[b,f]oxepin analogues of clozapine to dopamine and serotonin receptors.
    Phillips ST; de Paulis T; Neergaard JR; Baron BM; Siegel BW; Seeman P; Van Tol HH; Guan HC; Smith HE
    J Med Chem; 1995 Feb; 38(4):708-14. PubMed ID: 7861418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of naloxone in laboratory tests predictive of clinical antipsychotic activity.
    Malick JB; Billingsley ML; Kubena RK; Goldstein JM
    Commun Psychopharmacol; 1977; 1(5):475-88. PubMed ID: 23920
    [No Abstract]   [Full Text] [Related]  

  • 19. Buspirone: chemical profile of a new class of anxioselective agents.
    Temple DL; Yevich JP; New JS
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):4-10. PubMed ID: 6185470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological study of the thiophene analogue of taclamine, QM-7184, a new neuroleptic drug with potent alpha-adrenoceptor blocking activity.
    Arribas E; Vega S; Benito C; Fernandez-Tome MP; del Rio J
    Arzneimittelforschung; 1983; 33(10):1417-21. PubMed ID: 6140017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.